UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 778

Sortiert nach

Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of β -Glucuronidases in Their Disposition

Drug metabolism and disposition, 2017-06, Vol.45 (6), p.657-665

2017

Link zum Volltext

Verfügbarkeit prüfen

Disposition and metabolic profiling of [(14)C]cerlapirdine using accelerator mass spectrometry

Drug metabolism and disposition, 2014-12, Vol.42 (12), p.2023

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, Disposition, and Biotransformation of [ 14 C]Omecamtiv Mecarbil in Healthy Male Subjects after a Single Intravenous or Oral Dose

Drug metabolism and disposition, 2021-08, Vol.49 (8), p.619-628

2021

Link zum Volltext

Verfügbarkeit prüfen

Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites

Drug metabolism and disposition, 2013-06, Vol.41 (6), p.1179

2013

Link zum Volltext

Verfügbarkeit prüfen

Absorption, Metabolism, Excretion, and the Contribution of Intestinal Metabolism to the Oral Disposition of [14C]Cobimetinib, a MEK Inhibitor, in Humans

Drug metabolism and disposition, 2016-01, Vol.44 (1), p.28-39

2016

Link zum Volltext

Verfügbarkeit prüfen

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans

Drug metabolism and disposition, 2008-02, Vol.36 (2), p.386

2008

Link zum Volltext

Verfügbarkeit prüfen

Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites

Drug metabolism and disposition, 2015-08, Vol.43 (8), p.1190-1207

2015

Link zum Volltext

Verfügbarkeit prüfen

Predicting Maternal-Fetal Disposition of Fentanyl Following Intravenous and Epidural Administration Using Physiologically Based Pharmacokinetic Modeling

Drug metabolism and disposition, 2021-11, Vol.49 (11), p.1003-1015

2021

Link zum Volltext

Verfügbarkeit prüfen

The metabolism and disposition of the oral dipeptidyl peptidase-4 inhibitor, linagliptin, in humans

Drug metabolism and disposition, 2010-04, Vol.38 (4), p.667

2010

Link zum Volltext

Verfügbarkeit prüfen

The Disposition and Metabolism of Bempedoic Acid, a Potent Inhibitor of ATP Citrate Lyase, in Healthy Human Subjects

Drug metabolism and disposition, 2023-05, Vol.51 (5), p.599-609

2023

Link zum Volltext

Verfügbarkeit prüfen

Metabolic Disposition of Osimertinib in Rats, Dogs, and Humans: Insights into a Drug Designed to Bind Covalently to a Cysteine Residue of Epidermal Growth Factor Receptor

Drug metabolism and disposition, 2016-08, Vol.44 (8), p.1201-1212

2016

Link zum Volltext

Verfügbarkeit prüfen

Disposition and metabolism of [14C]SB-649868, an orexin 1 and 2 receptor antagonist, in humans

Drug metabolism and disposition, 2011-02, Vol.39 (2), p.215

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of Rifampin on the Disposition of Brivaracetam in Human Subjects: Further Insights into Brivaracetam Hydrolysis

Drug metabolism and disposition, 2016-06, Vol.44 (6), p.792-799

2016

Link zum Volltext

Verfügbarkeit prüfen

Metabolism and disposition of imatinib mesylate in healthy volunteers

Drug metabolism and disposition, 2005-10, Vol.33 (10), p.1503

2005

Link zum Volltext

Verfügbarkeit prüfen

Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme

Drug metabolism and disposition, 2007-09, Vol.35 (9), p.1657

2007

Link zum Volltext

Verfügbarkeit prüfen

Metabolism and disposition of [14C]BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor, after oral administration to humans

Drug metabolism and disposition, 2010-11, Vol.38 (11), p.2049

2010

Link zum Volltext

Verfügbarkeit prüfen

Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism

Drug metabolism and disposition, 2003-01, Vol.31 (1), p.98

2003

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, metabolism, and disposition of deferasirox in beta-thalassemic patients with transfusion-dependent iron overload who are at pharmacokinetic steady state

Drug metabolism and disposition, 2010-05, Vol.38 (5), p.808

2010

Link zum Volltext

Verfügbarkeit prüfen

Metabolism and disposition of isoflavone conjugated metabolites in humans after ingestion of kinako

Drug metabolism and disposition, 2011-09, Vol.39 (9), p.1762

2011

Link zum Volltext

Verfügbarkeit prüfen

The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human

Drug metabolism and disposition, 2003-06, Vol.31 (6), p.731

2003

Link zum Volltext

Verfügbarkeit prüfen

Disposition and metabolism of the cathepsin K inhibitor odanacatib in humans

Drug metabolism and disposition, 2014-05, Vol.42 (5), p.818

2014

Link zum Volltext

Verfügbarkeit prüfen

Disposition and metabolism of LY2452473, a selective androgen receptor modulator, in humans

Drug metabolism and disposition, 2012-12, Vol.40 (12), p.2354

2012

Link zum Volltext

Verfügbarkeit prüfen

Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytes

Drug metabolism and disposition, 2013-02, Vol.41 (2), p.296

2013

Link zum Volltext

Verfügbarkeit prüfen

Gene expression profiling of systems involved in the metabolism and the disposition of xenobiotics: comparison between human intestinal biopsy samples and colon cell lines

Drug metabolism and disposition, 2012-04, Vol.40 (4), p.694

2012

Link zum Volltext

Verfügbarkeit prüfen

Metabolism and disposition of the metabotropic glutamate receptor 5 antagonist (mGluR5) mavoglurant (AFQ056) in healthy subjects

Drug metabolism and disposition, 2013-09, Vol.41 (9), p.1626

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 778

Suche als RSS-Feed

Aktive Filter

KollektionSociological Abstracts

Zeitschrift / SerieBiopharmaceutics & Drug Disposition

Zeitschrift / SerieThe American Journal Of Emergency Medicine

Zeitschrift / SerieDrug Metabolism And Disposition

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(778)
Mit Volltextzugriff
(152)

Publikationsform

Artikel
(778)

Sprache

Englisch
(778)
Japanisch
(175)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(778)
Elektronische Zeitschriftenbibliothek (Open access)
(778)
Standalone journals
(778)

Menü

Weitere Dienste

Einstellungen

Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of β -Glucuronidases in Their Disposition

Disposition and metabolic profiling of [(14)C]cerlapirdine using accelerator mass spectrometry

Pharmacokinetics, Disposition, and Biotransformation of [ 14 C]Omecamtiv Mecarbil in Healthy Male Subjects after a Single Intravenous or Oral Dose

Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites

Absorption, Metabolism, Excretion, and the Contribution of Intestinal Metabolism to the Oral Disposition of [14C]Cobimetinib, a MEK Inhibitor, in Humans

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans

Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites

Predicting Maternal-Fetal Disposition of Fentanyl Following Intravenous and Epidural Administration Using Physiologically Based Pharmacokinetic Modeling

The metabolism and disposition of the oral dipeptidyl peptidase-4 inhibitor, linagliptin, in humans

The Disposition and Metabolism of Bempedoic Acid, a Potent Inhibitor of ATP Citrate Lyase, in Healthy Human Subjects

Metabolic Disposition of Osimertinib in Rats, Dogs, and Humans: Insights into a Drug Designed to Bind Covalently to a Cysteine Residue of Epidermal Growth Factor Receptor

Disposition and metabolism of [14C]SB-649868, an orexin 1 and 2 receptor antagonist, in humans

Effect of Rifampin on the Disposition of Brivaracetam in Human Subjects: Further Insights into Brivaracetam Hydrolysis

Metabolism and disposition of imatinib mesylate in healthy volunteers

Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme

Metabolism and disposition of [14C]BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor, after oral administration to humans

Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism

Pharmacokinetics, metabolism, and disposition of deferasirox in beta-thalassemic patients with transfusion-dependent iron overload who are at pharmacokinetic steady state

Metabolism and disposition of isoflavone conjugated metabolites in humans after ingestion of kinako

The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human

Disposition and metabolism of the cathepsin K inhibitor odanacatib in humans

Disposition and metabolism of LY2452473, a selective androgen receptor modulator, in humans

Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytes

Gene expression profiling of systems involved in the metabolism and the disposition of xenobiotics: comparison between human intestinal biopsy samples and colon cell lines

Metabolism and disposition of the metabotropic glutamate receptor 5 antagonist (mGluR5) mavoglurant (AFQ056) in healthy subjects

Aktive Filter

Suchergebnisse filtern